Clinical and Laboratory Study of Sickle Cell/β-Thalassemia

Authors

Koichi Maeda
Ellis J. Van Slyck
Robert C. Hawley

Abstract

We have studied 39 patients doubly heterozygous for sickle cell/β-thalassemia, 12 with sickle cell/β^o- thalassemia and 27 with sickle cell/β⁺-thalassemia. Generally, sickle cell/β^o-thalassemia is considered more severe than sickle cell/β⁺-thalassemia. In our study, however clinical complications in the group with sickle cell/β⁺-thalassemia were seen almost as frequently as in the group with sickle cell/β^o-thalassemia. A wide variety of clinical manifestations were seen in both groups of patients.

Recommended Citation

Maeda, Koichi; Van Slyck, Ellis J.; and Hawley, Robert C. (1986) "Clinical and Laboratory Study of Sickle Cell/β-Thalassemia," Henry Ford Hospital Medical Journal : Vol. 34 : No. 4 , 282-284.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol34/iss4/14